GluBio Therapeutics
GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.
GluBio Therapeutics is a business in biotechnology, health care, medical based in Asia-Pacific (APAC), founded in 2021.
GluBio Therapeutics is positioned in biotechnology, health care, medical, a segment that rewards a clear, focused offering.
The company is recorded as being based in Asia-Pacific (APAC).
Its current recorded stage is Series_A.
The company reports a headcount in the c_00011_00050 range.
It has disclosed roughly $72M in funding.
| Sector | Biotechnology, Health Care, Medical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2021 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $72,000,000 |
Website: www.glubiotx.com
Sign in to view the contact information we hold for GluBio Therapeutics.
Create a free account
Create a free account